$TWST
Twist Bioscience Corp

2019 Q3 Form 10-Q Financial Statement

#000119312519218039 Filed on August 09, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2019 Q2 2018 Q2
Revenue $15.74M $13.60M $6.541M
YoY Change 87.16% 107.92% 105.69%
Cost Of Revenue $12.39M $11.39M $7.503M
YoY Change 36.3% 51.86% 20.63%
Gross Profit $3.350M $2.206M -$962.0K
YoY Change -585.51% -329.31% -68.36%
Gross Profit Margin 21.28% 16.22% -14.71%
Selling, General & Admin $24.42M $21.32M $11.26M
YoY Change 88.57% 89.41% 90.14%
% of Gross Profit 728.96% 966.46%
Research & Development $10.50M $9.007M $5.268M
YoY Change 72.98% 70.98% -0.23%
% of Gross Profit 313.43% 408.3%
Depreciation & Amortization $1.490M $1.580M $1.700M
YoY Change 12.03% -7.06% -54.91%
% of Gross Profit 44.48% 71.62%
Operating Expenses $34.92M $30.33M $16.52M
YoY Change 83.6% 83.53% 47.54%
Operating Profit -$31.57M -$28.12M -$17.49M
YoY Change 60.17% 60.82% 22.79%
Interest Expense $500.0K $318.0K $337.0K
YoY Change 2400.0% -5.64% -324.67%
% of Operating Profit
Other Income/Expense, Net $0.00 -$227.0K -$14.00K
YoY Change -100.0% 1521.43% -110.0%
Pretax Income -$31.07M -$27.86M -$17.55M
YoY Change 57.48% 58.73% 23.18%
Income Tax $110.0K $54.00K $71.00K
% Of Pretax Income
Net Earnings -$31.18M -$27.92M -$17.62M
YoY Change 57.47% 58.4% 23.07%
Net Earnings / Revenue -198.09% -205.26% -269.44%
Basic Earnings Per Share
Diluted Earnings Per Share -$960.0K -$921.8K -$662.2K
COMMON SHARES
Basic Shares Outstanding 32.56M 28.04M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $138.1M $161.8M $92.50M
YoY Change 70.92% 74.92%
Cash & Equivalents $46.74M $68.21M $91.10M
Short-Term Investments $91.40M $93.60M $1.600M
Other Short-Term Assets $2.600M $3.600M $2.700M
YoY Change -25.71% 33.33%
Inventory $7.330M $5.496M $4.300M
Prepaid Expenses
Receivables $12.10M $11.70M $4.300M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $160.1M $182.6M $103.8M
YoY Change 67.38% 75.94%
LONG-TERM ASSETS
Property, Plant & Equipment $20.84M $19.82M $12.80M
YoY Change 68.96% 54.82%
Goodwill $1.138M $1.138M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.799M $2.090M $4.200M
YoY Change -29.12% -50.24%
Total Long-Term Assets $26.86M $24.18M $18.90M
YoY Change 33.49% 27.95%
TOTAL ASSETS
Total Short-Term Assets $160.1M $182.6M $103.8M
Total Long-Term Assets $26.86M $24.18M $18.90M
Total Assets $187.0M $206.8M $122.7M
YoY Change 61.49% 68.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.760M $7.835M $4.500M
YoY Change 29.6% 74.11%
Accrued Expenses $5.965M $3.713M $6.000M
YoY Change 175.39% -38.12%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.333M $3.333M $1.700M
YoY Change 33.32% 96.06%
Total Short-Term Liabilities $30.35M $25.45M $18.10M
YoY Change 63.75% 40.59%
LONG-TERM LIABILITIES
Long-Term Debt $4.400M $5.119M $287.1M
YoY Change -39.04% -98.22%
Other Long-Term Liabilities $158.0K $236.0K $300.0K
YoY Change -54.07% -21.33%
Total Long-Term Liabilities $4.558M $5.355M $287.4M
YoY Change -39.72% -98.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $30.35M $25.45M $18.10M
Total Long-Term Liabilities $4.558M $5.355M $287.4M
Total Liabilities $34.91M $30.80M $305.4M
YoY Change 30.61% -89.91%
SHAREHOLDERS EQUITY
Retained Earnings -$318.5M -$287.3M
YoY Change 51.06%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $152.1M $176.0M -$182.8M
YoY Change
Total Liabilities & Shareholders Equity $187.0M $206.8M $122.7M
YoY Change 61.49% 68.55%

Cashflow Statement

Concept 2019 Q3 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$31.18M -$27.92M -$17.62M
YoY Change 57.47% 58.4% 23.07%
Depreciation, Depletion And Amortization $1.490M $1.580M $1.700M
YoY Change 12.03% -7.06% -54.91%
Cash From Operating Activities -$23.36M -$22.08M -$16.94M
YoY Change 39.96% 30.34% -57.48%
INVESTING ACTIVITIES
Capital Expenditures -$3.900M -$5.170M -$630.0K
YoY Change 271.43% 720.63% -80.67%
Acquisitions
YoY Change
Other Investing Activities $2.710M -$17.53M $5.210M
YoY Change 86.9% -436.47% -32.51%
Cash From Investing Activities -$1.190M -$22.70M $4.580M
YoY Change -390.24% -595.63% 2.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $84.30M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.930M 84.28M 24.83M
YoY Change -55.47% 239.43% -60.42%
NET CHANGE
Cash From Operating Activities -23.36M -22.08M -16.94M
Cash From Investing Activities -1.190M -22.70M 4.580M
Cash From Financing Activities 2.930M 84.28M 24.83M
Net Change In Cash -21.62M 39.50M 12.47M
YoY Change 122.89% 216.76% -54.42%
FREE CASH FLOW
Cash From Operating Activities -$23.36M -$22.08M -$16.94M
Capital Expenditures -$3.900M -$5.170M -$630.0K
Free Cash Flow -$19.46M -$16.91M -$16.31M
YoY Change 24.42% 3.68% -55.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 us-gaap Goodwill
Goodwill
1138000
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5360000
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
25447000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12331000
CY2018Q3 us-gaap Goodwill
Goodwill
1138000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19817000
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5419000
CY2019Q2 us-gaap Short Term Investments
ShortTermInvestments
93575000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11697000
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2090000
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3467000
CY2018Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7218000
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
344000
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3642000
CY2019Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5119000
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
236000
CY2019Q2 us-gaap Liabilities
Liabilities
30802000
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Liabilities
Liabilities
26730000
CY2018Q3 twst Convertible Preferred Stock Warrant Liability
ConvertiblePreferredStockWarrantLiability
631000
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7531000
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2166000
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5401000
CY2018Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2500000
CY2018Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
939000
CY2018Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
290483000
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9346000
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
87000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-210855000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
115791000
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7835000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3713000
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9886000
CY2019Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
3333000
CY2019Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
680000
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
463229000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
117000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-287343000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
176003000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
206805000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
18537000
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
27775000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3206048
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3206048
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32471591
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32471591
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
7503000
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
11394000
us-gaap Cost Of Revenue
CostOfRevenue
23096000
us-gaap Cost Of Revenue
CostOfRevenue
35041000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5268000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9007000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14282000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25186000
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11256000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21320000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30497000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
55703000
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
24027000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
41721000
us-gaap Costs And Expenses
CostsAndExpenses
67875000
us-gaap Costs And Expenses
CostsAndExpenses
115930000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17486000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-28121000
us-gaap Operating Income Loss
OperatingIncomeLoss
-50855000
us-gaap Operating Income Loss
OperatingIncomeLoss
-77282000
CY2018Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
284000
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
804000
us-gaap Investment Income Interest
InvestmentIncomeInterest
590000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2243000
CY2018Q2 us-gaap Interest Expense
InterestExpense
337000
CY2019Q2 us-gaap Interest Expense
InterestExpense
318000
us-gaap Interest Expense
InterestExpense
927000
us-gaap Interest Expense
InterestExpense
1007000
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-227000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-76000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-263000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-17553000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-27862000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-51268000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-76309000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
71000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
166000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
179000
CY2019Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
161787000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13000
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14000
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
250000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
35000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
17000
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17610000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27663000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-51399000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-76458000
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.18
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.92
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-18.92
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.97
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
115480000
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
84255000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
899000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-201422000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
153852000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1131000
twst Stock Issued During Period Value Conversion Of Convertible Warrant
StockIssuedDuringPeriodValueConversionOfConvertibleWarrant
631000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
290462000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-165721000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
-133358000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
123000
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-31000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80757000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68212000
CY2018Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
579000
CY2019Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
579000
CY2018Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
201000
CY2019Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
194000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81537000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
68985000
CY2018Q3 us-gaap Deferred Costs
DeferredCosts
3700000
twst Deferred Offering Costs Incurred
DeferredOfferingCostsIncurred
2400000
CY2018Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
80757000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-17624000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-27916000
us-gaap Net Income Loss
NetIncomeLoss
-51434000
us-gaap Net Income Loss
NetIncomeLoss
-76488000
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2849544000
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30290150000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2719051000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25789794000
CY2018Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
2988000
CY2019Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
2995000
CY2018Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
2273000
CY2019Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1373000
CY2018Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
767000
CY2019Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1128000
CY2018Q3 us-gaap Inventory Net
InventoryNet
6028000
CY2019Q2 us-gaap Inventory Net
InventoryNet
5496000
CY2018Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1240000
CY2018Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
528000
CY2018Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
712000
CY2019Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1240000
CY2019Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
681000
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
559000
CY2018 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2018Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
700000
CY2019Q2 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
500000
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
1800000
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
2600000
us-gaap Profit Loss
ProfitLoss
-51434000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4398000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4622000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-55000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-202000
us-gaap Share Based Compensation
ShareBasedCompensation
1875000
us-gaap Share Based Compensation
ShareBasedCompensation
7807000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
968000
us-gaap Other Noncash Expense
OtherNoncashExpense
150000
us-gaap Other Noncash Expense
OtherNoncashExpense
182000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
66000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
230000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
219000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1943000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6108000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2426000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-532000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
796000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
122000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1452000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
442000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1539000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-96000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
518000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1961000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-90000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4475000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-158000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-355000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2641000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10864000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
17000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3374000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
137264000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
32900000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
44500000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
26902000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-103623000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
291000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1109000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
156208000
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
83873000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1925000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1667000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31429000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
91102000
us-gaap Interest Paid Net
InterestPaidNet
587000
us-gaap Interest Paid Net
InterestPaidNet
605000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
59673000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12552000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
20000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
221000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
1273000
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
516000
twst Conversion Of Convertible Preferred Stock Warrant
ConversionOfConvertiblePreferredStockWarrant
631000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
290462000
CY2019Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
25500000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3032000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
253000
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-27916000
CY2018Q3 twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrant
860287
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2520485
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.22
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M17D
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11483000
twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant Additional Shares Authorized In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantAdditionalSharesAuthorizedInPeriod
2494700
twst Share Based Compensation Arrangement By Share Based Payment Award Number Of Options Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOptionsAvailableForGrant
1618676
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1618676
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
25.21
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
191599
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.95
twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantForfeited
340899
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
340899
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
15.93
twst Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Restricted Stock Units Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantRestrictedStockUnitsGrantedInPeriod
500132
twst Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Restricted Stock Units Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantRestrictedStockUnitsForfeited
24221
twst Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Repurchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsRepurchased
442
CY2019Q2 twst Share Based Compensation Arrangement By Share Based Payment Award Options Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrant
1601741
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3606663
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.24
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.24
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y4M27D
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
50051000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y7M6D
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
50051000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M27D
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
603000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3032000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1875000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7807000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7807000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
30000
twst Net Exercise Of Common Stock Warrants Values
NetExerciseOfCommonStockWarrantsValues
0
CY2018Q4 twst Net Exercise Of Common Stock Warrants Shares
NetExerciseOfCommonStockWarrantsShares
68901
CY2018Q4 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
57122
twst Underwriting Discounts Commissions And Offering Expenses
UnderwritingDiscountsCommissionsAndOfferingExpenses
17210000
CY2019Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
84300000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-182759000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
3606663
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1875000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
35000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
603000
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
14000
CY2018Q2 us-gaap Profit Loss
ProfitLoss
-17624000
CY2019Q2 twst Underwriting Discounts Commissions And Offering Expenses
UnderwritingDiscountsCommissionsAndOfferingExpenses
6307000
CY2018Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one-for-0.101
CY2018Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.101
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49468000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-64579000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
82239000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
155650000
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6541000
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13600000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17020000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
38648000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21149714
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4392669
dei Trading Symbol
TradingSymbol
TWST
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32558888
dei Security12b Title
Security12bTitle
Common Stock
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2018Q3 us-gaap Assets Current
AssetsCurrent
95671000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
182622000
CY2018Q3 us-gaap Assets
Assets
115791000
CY2019Q2 us-gaap Assets
Assets
206805000
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
During the three months ended June 30, 2018 and 2019, the Company purchased raw materials from a related party investor in the amount of $0.7 million and $0.5 million, respectively. During the nine months ended June 30, 2018 and 2019, the Company purchased raw materials from a related party investor in the amount of $1.8 million and $2.6 million, respectively. Payable balances and cash receipts and receivable balances with the related parties were immaterial as of September 30, 2018 and June 30, 2019.
us-gaap Profit Loss
ProfitLoss
-76488000
dei Document Type
DocumentType
10-Q
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
Twist Bioscience Corp
dei Entity Central Index Key
EntityCentralIndexKey
0001581280
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Shell Company
EntityShellCompany
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true

Files In Submission

Name View Source Status
0001193125-19-218039-index-headers.html Edgar Link pending
0001193125-19-218039-index.html Edgar Link pending
0001193125-19-218039.txt Edgar Link pending
0001193125-19-218039-xbrl.zip Edgar Link pending
d748609d10q.htm Edgar Link pending
d748609dex311.htm Edgar Link pending
d748609dex312.htm Edgar Link pending
d748609dex321.htm Edgar Link pending
d748609dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g748609g98e14.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
twst-20190630.xml Edgar Link completed
twst-20190630.xsd Edgar Link pending
twst-20190630_cal.xml Edgar Link unprocessable
twst-20190630_def.xml Edgar Link unprocessable
twst-20190630_lab.xml Edgar Link unprocessable
twst-20190630_pre.xml Edgar Link unprocessable